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The reversible phosphorylation of serine, threonine and tyrosine hydroxyl groups is an especially prominent form of
post-translational modification (PTM) of proteins. It plays critical roles in the regulation of diverse processes, and mutations
that directly or indirectly affect these phosphorylation events have been associated with many cancers and other pathol-
ogies. Here, we describe the development of a new BioMart tool that gathers data from three different biological resources
to provide the user with an integrated view of phosphorylation events associated with a human protein of interest, the
complexes of which the protein (modified or not) is a part, the reactions in which the protein and its complexes participate
and the somatic mutations that might be expected to perturb those functions. The three resources used are the Reactome,
PRIDE and COSMIC databases. The Reactome knowledgebase contains annotations of phosphorylated human proteins
linked to the reactions in which they are phosphorylated and dephosphorylated, to the complexes of which they are
parts and to the reactions in which the phosphorylated proteins participate as substrates, catalysts and regulators. The
PRIDE database holds extensive mass spectrometry data from which protein phosphorylation patterns can be inferred, and
the COSMIC database holds records of somatic mutations found in human cancer cells. This tool supports both flexible,
user-specified queries and standard (‘canned’) queries to retrieve frequently used combinations of data for user-specified
proteins and reactions. We demonstrate using the Wnt signaling pathway and the human c-SRC protein how the tool can
be used to place somatic mutation data into a functional perspective by changing critical residues involved in pathway
modulation, and where available, check for mass spectrometry evidence in PRIDE supporting identification of the critical
residue.
Database URL: http://www.reactome.org/cgi-bin/mart
.............................................................................................................................................................................................................................................................................................
Introduction
Covalent modification of amino acid residues (‘post-
translational modification’, PTM) is an important part of
the molecular toolkit used by many organisms to generate
full sets of functional forms of proteins from the relatively
limited sets of open reading frames specified in their
genomes. The reversible phosphorylation of serine, threo-
nine and tyrosine residues is the most frequent PTM in the
mammalian proteome (1). Approximately 30% of all pro-
teins in a human cell are phosphorylated at any given time
(2). Reversible phosphorylation of proteins through the
activity of protein kinases and phosphatases have been
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.............................................................................................................................................................................................................................................................................................exploited by nature to modify the function of a protein in
almost every conceivable way: increasing or decreasing its
biological activity, stabilizing it or marking it for destruc-
tion, facilitating or inhibiting movement between cellular
compartments and initiating or disrupting protein–protein
interactions (2), thereby regulating almost all aspects of cell
function and cell–cell interaction in processes including dif-
ferentiation, proliferation and migration. The disruption of
normal phosphorylation states of intracellular proteins by
pathogens, toxins or mutations is associated with many dis-
eases and disorders (2), and development of drugs that
target specific protein kinases and phosphatases is the
focus of active research.
Mass spectrometry (MS) is currently the most commonly
used technology for the identification and quantification of
proteins. Technological advances in proteomics have
enabled identification of protein modifications as well as
protein subcellular location(s) allowing researchers to gain
an accurate picture of cellular processes (3). The resulting
MS data can be deposited in proteomics databases such as
PRIDE (PRoteomics IDEntifications database, http://www
.ebi.ac.uk/pride) (4). PRIDE is a standards-compliant public
repository of MS-derived data. It stores MS and MS/MS mass
spectra as peak lists, the derived peptide and protein iden-
tifications, as well as PTMs and experimental metadata.
Biologists commonly represent the biochemical processes
that take place at a subcellular level as networks of reac-
tions, called pathways. A familiar example is the citric acid
cycle. Reactome (http://www.reactome.org) (5) is a data-
base of human pathways specified in molecular detail.
The data are contributed by expert biologists, supported
by literature and undergoes an iterative curation and
peer-review process. It encompasses a wide variety of bio-
logical processes, such as metabolism, signaling, apoptosis,
transcription and the cell cycle. Reactome makes extensive
use of molecular complexes, particularly protein complexes.
The website provides facilities for browsing and viewing
the pathways, plus tools for analyzing user-supplied data
in a pathway context. Various export formats are provided
in order to make the content accessible to the systems biol-
ogy community. All Reactome software and data are avail-
able under the terms of the Creative Commons Attribution
3.0 Unported License.
The catalog of somatic mutations in cancer (COSMIC)
(http://www.sanger.ac.uk/genetics/CGP/cosmic/) (6)i sa
database that gathers, curates, organizes and presents som-
atic mutations in human cancer.
The Reactome, PRIDE and COSMIC databases all employ
a BioMart interface (http://www.biomart.org) (7) on their
websites for data integration. BioMart is an open source
data management resource, which provides a variety of
query interfaces enabling users to group and refine data,
based upon many different criteria. It provides a web inter-
face with a consistent look and feel and performs
federated queries across different databases such as
Ensembl (8) and UniProt (9) as well as PRIDE and
Reactome—located on different servers or at different geo-
graphical locations. Federation utilizes shared common
identifiers (IDs) e.g. Ensembl gene IDs, UniProt IDs.
Development of a new BioMart
tool
BioMart has its own special data structure in order to allow
very fast queries and efficient federation. It structures the
user’s data into databases, which contain data sets. This
allows the BioMart database designer to separate data
into different types. The standard Reactome BioMart (10)
has four data sets, pathway, reaction, complex and inter-
action. The pathway data set allows users to retrieve ID,
name, species and several other attributes from all of
Reactome’s pathways. It also uses dimension tables so
that proteins, complexes and literature references asso-
ciated with each pathway can also be retrieved. A large
set of filters is provided, so that a user can, for instance, find
all of the pathways associated with a given set of UniProt
IDs. The reaction and complex data sets are structured very
similarly to the pathway data set.
The PRIDE BioMart can be used to interrogate the three
different kinds of information stored—peptide and protein
identifications derived from MS or MS/MS experiments, MS
and MS/MS mass spectra as peak lists and any associated
metadata. It also provides filtering by experiment, sample
details, peptide identification, protein identification,
mapped protein IDs and protein modification.
The COSMICMart (11) consists of a single data set, which
allows users to retrieve information about the sample,
gene, mutation, site and histology, plus details such as
Entrez, UniProt, Ensembl gene, PubMed and COSMIC
study IDs. A large set of filters is provided, so that users
can, for instance, find all the somatic mutations together
with the sample details associated with a given set of
UniProt IDs. In this article, we describe data integration
from Reactome, PRIDE and COSMIC databases, based on
updated data sets and newly created ‘canned’ queries.
The protein data set in Reactome
We have created a new data set in Reactome BioMart,
‘Protein’, to enable users to explore PTM details for a pro-
tein and retrieve information such as the cellular compart-
ment of the protein, the name of the modification, the
modified residue, the coordinate of the modified residue
on the protein sequence and the start and stop positions
of the protein sequence. In terms of data integration, the
data set can be interrogated in conjunction with other pre-
existing Reactome data sets e.g. pathway, complex and
.............................................................................................................................................................................................................................................................................................
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share IDs e.g. UniProt, Ensembl and PSI-MOD IDs.
To federate two data sets, BioMart’s MartEditor tool pro-
vides the means to edit each data set’s configuration XML
by defining an ordered list of attributes that are common
between the two data sets. The attributes from a data set
to be shared with the second data set are referred to as the
exportables, while those from another dataset to be used
as filters in querying the dataset are referred to as import-
ables. For a data set to link to a second data set, an import-
able needs to be created in that data set with the same
linkName setting as the exportable. The linkName can
either use a single-filter value system for the importable
e.g. UniProt ID, or a multifilter value system as required
e.g. for a combination of UniProt and PSI-MOD (12) IDs,
as long as the attribute value(s) of the corresponding ex-
portable are specified in the same order as the importable.
We used BioMart’s capability of federating between
multiple data sets based on shared IDs to define import-
ables and exportables available for this data set. To link
to PRIDE’s modification location table described below, a
two-filter/attribute importable and exportable were
defined using the shared UniProt and PSI-MOD IDs, while
to link to the COSMICMart data set, the two-filter/attribute
values were based on shared UniProt ID and modified/
mutated residue position.
The Modification Location table in PRIDE
The ‘Mapped Protein Modification (PTM) to UniProt
Proteins Attributes—Reactome Link’ table on PRIDE
BioMart data set was specifically created to capture phos-
phorylated proteins and their associated details such as the
location of the modification, name of the modification,
sample information including species, tissue, sub-cellular lo-
cation and/or disease state, the sample used, and the spec-
trum for each peptide that was used in identifying the
protein. The Resid (13) and Unimod (14) ontology terms
were manually mapped to PSI-MOD (12) terms by a PRIDE
curator for integration with Reactome’s ‘Protein’ data set,
in order to link protein modification information (PSI-MOD)
from a pathway context to MS data. All the low level
PSI-MOD terms were also mapped to a top level PSI-MOD
term i.e. all the serine, tyrosine and threonine phosphoryl-
ations have been mapped to modified residue terms, to
simplify matching these terms across the two databases.
The COSMICMart data set
COSMICMart allows users to query genes, tissues and mu-
tations information from the samples available in the
COSMIC database and to federate these with other data-
sets such as Ensembl. An update has recently been made to
enable the new Reactome protein data set to link to the
COSMIC data set: a two-filter/attribute importable and ex-
portable were defined based on the shared UniProt IDs and
modified/mutated residue position, respectively. The single
input value filter ’Swissprot ID’ was changed to a multiva-
lued input filter to allow users to query the data set using
more than one UniProt ID. In addition, links were created
from COSMICMart’s AA Mutation Start and AA Mutation
Stop position attributes to the COSMIC gene histogram
page, giving the user a graphical view of the spread of
mutations in their region of interest on the gene sequence.
The gene histogram page also offers a number of options
for filtering the data, as well as pie charts, accessible by
clicking the distribution button, summarizing the data.
Database integration
Based on the updated data sets, the Reactome BioMart can
retrieve and integrate protein phosphorylation data
derived from expert manual curation of the research litera-
ture (from Reactome) with data from high-throughput MS
experiments (from PRIDE), link these data to known muta-
tions affecting the amino acid sequences of proteins (from
COSMIC) and to the roles of these proteins in complexes
and reactions (from Reactome). A user might approach
this system from the point of view of a protein of interest,
seeking information on its modifications and their effects
on its functions, or might approach from the point of view
of a process of interest, seeking information on the pro-
teins and complexes involved in it. We have developed
‘canned’ queries to facilitate these approaches. The
‘canned’ queries are also starting points from which a
user can develop customized queries. The examples de-
scribed here illustrate useful ‘canned’ approaches and one
way in which such an approach might be customized.
Queries to retrieve modified
proteins from Reactome data sets
Users can retrieve modified proteins and their associated
details from three Reactome data sets; pathway, complex
and reaction.
Query: ‘Find all modified proteins in a pathway’—this
query enables users to retrieve modified proteins asso-
ciated with Reactome pathway(s) of interest for further
analysis (Figure 1). After the user selects the query, a data
input page appears where Reactome Pathway name and
species can be selected (Figure 2). The query will be pro-
cessed and results presented in a BioMart results page
(Figure 3). The query spans the ‘Pathway’ and ‘Protein’
data sets.
Similarly, finding all modified proteins in a complex or
reaction can be retrieved with predefined queries.
Query: ‘Compare the modification locations in Reactome
& PRIDE’—to be able to compare which residues in a pro-
tein are reported to be modified in Reactome and their
corresponding positions with PRIDE MS experiments, the
.............................................................................................................................................................................................................................................................................................
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canned query can be used. The user enters the UniProt ID(s)
in a data input page and the results are presented in a
BioMart results page (Figure 4). This query spans the
Reactome ‘Protein’ and ‘PRIDE’ data sets.
Query: ‘Match modified proteins in Reactome & MS de-
tails in PRIDE’—after finding a matching or conflicting
modified residue position, one can then inspect the pep-
tides and the spectrum used to identify the modification.
The ‘Modified proteins in Reactome & Mass spectrometry
details in PRIDE’ canned query can be used to retrieve this
information. The user enters the UniProt ID(s) in a data
input page and the results are presented in a BioMart re-
sults page (Figure 5) with the option to view the spectrum
(Supplementary Figure S8). This query spans the ‘Protein’
and ‘PRIDE’ data sets.
Query: ‘Check if modified protein has known cancer mu-
tations’—users can also check if their protein of interest has
any known somatic mutations that are linked to cancer
through COSMIC by using the ‘Check if modified protein
has known cancer mutations’ canned query. The user
enters the UniProt ID(s) in a data input page and the results
are presented in a BioMart results page (Figure 6). This
query spans the ‘Protein’ and ‘COSMIC’ data sets.
Figure 2. Canned query data input page. The user selects the pathway and species names from the respective drop down lists
and then presses the ‘Run query’ button.
Figure 1. Select the appropriate canned query, in this case ‘Find all modified proteins in a pathway’.
.............................................................................................................................................................................................................................................................................................
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.............................................................................................................................................................................................................................................................................................Figure 3. Results of finding all modified proteins in a pathway. The user is then able to inspect the retrieved proteins
for the kinds of modification present on each protein (PSI-MOD), the modified residue in the protein, the cell
compartment of the modified protein and the position of the modified residue on the protein if known (Modified Residue
coordinate).
Figure 4. Results of comparing modification locations between Reactome and PRIDE. The modified protein’s UniProt ID, its
name, cellular compartment, the modified residue and its residue coordinate from Reactome are reported. PRIDE also reports
corresponding details of the protein present in their database i.e. location of modification on protein, PSI-MOD name, ID and the
UniProt Accession.
.............................................................................................................................................................................................................................................................................................
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Using two case studies, we illustrate the new Reactome,
COSMIC and PRIDE data integration that provides a new
way of looking at known information residing in different
databases.
Wnt Signaling
The canonical Wnt signaling pathway (doi: 10.3180/REACT_
11045.1) regulates the cytoplasmic levels of the b-catenin
protein that is involved in the activation of the Wnt target
genes in the nucleus thus playing an important role in reg-
ulating the balance between stemness and differentiation
in adult stem cell niches (15) such as skin and hair follicle
(16), the mammary gland (17) and hematopoietic tissues
(18). This pathway is regulated by the b-catenin destruction
complex, which comprises of the adenomatous polyposis
coli (APC), Axin 1/2, casein kinase 1 (CK1) and glycogen syn-
thase kinase-3b (GSK-3b) proteins. In the absence of Wnt
signaling, this complex controls the levels of cytoplasmic
b-catenin by amino-terminal serine/threonine phosphoryl-
ation of b-catenin at Serine 45 by CK1-a, which primes
the subsequent sequential GSK-3-mediated phosphoryl-
ation at threonine 41, serine 37 and serine 33 (19).
Phosphorylated b-catenin is recognized and ubiquitinated
by the SCF-b TrCP ubiquitin ligase complex and is subse-
quently degraded by the proteasome (20) (doi: 10.3180/
REACT_11063.1). It is therefore not surprising that
carcinogenesis is likely to be initiated in tissues with aber-
rant Wnt signaling activation due to mutations in genes
encoding its downstream components such as b-catenin
and the APC genes.
The b-catenin protein (UniProt Accession: P35222) pre-
sents an instance where critical residues that are normally
phosphorylated as part of the Wnt signaling pathway
modulation and reported in the Reactome database
(serine 45 and threonine 41), are mutated, leading to aber-
rant signaling associated with cancer as identified
using Query 4: ‘Check if modified protein has known
cancer mutations’. Each of the reported mutated residues
in COSMIC has a link to the gene histogram page (Figure 7)
by clicking either the value of AA Mutation Start or AA
Mutation Stop column. The gene view histogram presents
a graphical view of the spread of mutations in a region of
interest, in this case showing that the phosphorylated resi-
dues serine 45 and threonine 41 on the b-catenin protein
are lost.
The human c-SRC protein
The human cellular SRC (c-SRC), a nonreceptor tyrosine
kinase, is involved in numerous cellular processes such as
cell proliferation, regulation of cell adhesion, invasion
and motility, which are thought to contribute to tumor pro-
gression and metastasis, although this role is not yet fully
understood (21, 22). It has an N-terminal SH4 domain that
contains the myristoylation site needed for membrane
Figure 5. Results of matching modified proteins in Reactome with the MS details available in PRIDE. The peptide sequence and
the option to view the spectrum (Supplementary Figure S8) are returned in addition to the columns returned in Figure 4.
.............................................................................................................................................................................................................................................................................................
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binding to specific proline-rich sequences, SH2 domain
that binds to specific tyrosine phosphorylation, SH1 catalyt-
ic tyrosine kinase domain, which is the autophosphoryla-
tion site and a short C-terminal region containing a
conserved tyrosine residue. The two known functionally im-
portant tyrosine residues in the c-SRC protein are tyrosine
419 located in the SH1 catalytic tyrosine domain that is the
autophosphorylation site, and tyrosine 530 contained in
the short C-terminal region that is known to be the prin-
cipal regulatory phosphotyrosine. The phosphorylation of
c-SRC at C-terminal regulatory tyrosine 530 facilitates
intramolecular binding to the SH2 domain causing the pro-
tein to be inactivated, whereas the dephosphorylation of
tyrosine 530 disrupts this binding with the SH2 domain
facilitating the autophosphorylation of tyrosine 419 lead-
ing to c-SRC activation (23). A truncating mutation at codon
531 (Glutamine to stop) occurs directly at C-terminal
regulatory tyrosine 530 and appears to activate the tyro-
sine 530 in some cancers e.g. advanced colon cancers (22)
and in some cases of endometrial carcinoma (24).
Reactome reports both tyrosine 419 and tyrosine 530 as
functionally important residues, PRIDE reports tyrosine
419, whereas COSMIC reports the truncating mutation at
codon 531.
Comparison of curated
and high-throughput
phosphorylation data
Direct comparison of Reactome (Release 34) functional an-
notation with PRIDE (core version: 2.8.6, February 2011)
high-throughput phosphoproteomic data reveal inde-
pendent confirmation and highlights the potential for fur-
ther investigation in cases of differing observations
(Supplementary Table S1). A total of 13 unique protein ac-
cessions were retrieved from a Reactome-PRIDE BioMart
database match based on the two-filter uniProt/modified
residue position filter system. From these, PRIDE reports
a total of 43 phosphorylation sites occurring on either
serine or tyrosine residues, while Reactome reports 14
phosphorylation sites on the same residues. The two data-
bases corroborate on five modified residue positions
(Supplementary Figure S9) derived from five UniProt pro-
tein accessions (Supplementary Table S2).
The canned query ‘Compare the modification locations
in Reactome & PRIDE’ shows instances where PRIDE reports
more modified residue positions than those reported by
Reactome for a given protein. For example, Figure 4
shows where PRIDE reports six phosphorylated serine
Figure 6. Results of checking if the modified protein has known cancer mutations. The modified protein’s UniProt ID, the
COSMIC Sample ID and name, the gene name, the nucleotide and residue changes caused by the mutation, the zygosity, primary
histology, tumor source and the reference paper for the study are returned. By further choosing more attributes finer details can
be retrieved. The query spans the ‘Protein’ and ‘COSMIC’ data sets.
.............................................................................................................................................................................................................................................................................................
Page 7 of 10
Database, Vol. 2011, Article ID bar047, doi:10.1093/database/bar047 Original Article
.............................................................................................................................................................................................................................................................................................residues (at positions 49, 244, 528, 532, 556, 867) on
kinesin-like protein KIF20A (UniProt Accession: O95235),
whereas Reactome annotates the only modification with
known function (serine 528). This integration presents an
easy and systematic platform to compare critical residue
positions identified through traditional biochemical tech-
niques that are mainly limited to investigating how phos-
phorylation at specific sites affect a single protein of
interest (25), with high-throughput phosphoproteomics
approaches that have the ability to identify novel in vivo
phosphorylation sites on a large scale but with the poten-
tial risks of averaging over multiple cell types and states.
Modifications data, like all of Reactome’s data, are ob-
tained from literature, expert-authored, manually curated
and peer-reviewed before being added into the data-
base by a Reactome curator. The experimental evidence
of the reported modifications in PRIDE is obtained from
high-throughput MS proteomics experiments. In these
approaches, proteins are digested with a single protease,
typically trypsin, and the resulting peptides—modified or
not—are analyzed using a mass spectrometer (26). This ex-
perimental workflow has strengths and limitations that
have been widely described before (27–29). This data will
serve as a tool for validation and the potential addition of
functional modification sites in Reactome.
Discussion
We have applied a key feature of BioMart, namely its cap-
ability to formulate queries across multiple independent
BioMart installations, to link manually curated pathway
data in Reactome to high-throughput phosphoproteomics
data in PRIDE and somatic mutation data in COSMIC.
Figure 7. A COSMIC Gene View histogram from clicking the ‘AA mutation start or AA mutation stop’ position. The amino acid
serine at position 45 is mutated to a phenylalanine.
.............................................................................................................................................................................................................................................................................................
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Reactome and PRIDE matched their phosphorylation pos-
itions perfectly, with PRIDE having more phosphorylations
sites identified through high-throughput experiments.
Once these additional phosphorylation sites are validated
independently, they may or may not be functionally rele-
vant and might then be added to Reactome annotation.
The traditional concept of a functional active site is based
on the assumption that protein phosphorylation modulates
protein function through the specific position of the phos-
phorylation in the protein sequence. However, it has been
recently argued that nonpositionally conserved phosphor-
ylation sites may very well be functional, as the authors
speculate that the nonpositionally conserved phosphoryl-
ation sites could be modulating biomolecular association
of phosphorylated proteins possibly by fine-tuning the pro-
tein’s bulk electrostatic charge and by creating binding sites
for phospho-binding interaction domains (30). This re-
source could be used to identify and differentiate the non-
positionally conserved modified sites.
Annotated, functionally relevant phosphorylation sites
in Reactome might be used as independent confirmation
for a test set of high-confidence phosphoproteomics spec-
tra, which is highly valuable for MS methods development.
Preliminary results in Wnt signaling link known somatic mu-
tation to annotated, functionally relevant phosphorylation
sites in the Wnt pathway representation in Reactome, and
thus to possible interpretation of carcinogenic effects of
these mutations. We plan to extend our approach to
other functionally relevant PTMs such as ubiquitination,
acetylation and myristoylation.
Supplementary Data
Supplementary Data are available at Database online.
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